{"entity":{"type":"insider","cik":"0001618233","url":"/insider/0001618233","json_url":"/insider/0001618233.json","name":"Herick Gary J","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":27,"n_filings":2,"first":"2019-04-17","last":"2019-04-18","span_basis":"filed_date"},"name_variants":[{"name":"Herick Gary J","source":"filing","n_filings":2,"first_seen":"2019-04-17","last_seen":"2019-04-18"}],"transactions":[{"id":8096378,"accession":"0001128732-19-000010","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-27","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400000.0,"shares_display":"400,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":800000.0,"total_display":"800,000.00","shares_owned_after":400000.0,"shares_owned_after_display":"400,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-04-17","scope":"insider"},{"id":8096376,"accession":"0001128732-19-000010","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-26","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","shares_owned_after":600000.0,"shares_owned_after_display":"600,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-04-17","scope":"insider"},{"id":8096374,"accession":"0001128732-19-000010","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-25","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","shares_owned_after":500000.0,"shares_owned_after_display":"500,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-01-02","filed_date":"2019-04-17","scope":"insider"},{"id":8096372,"accession":"0001128732-19-000010","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-24","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":123500.0,"shares_display":"123,500","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":61750.0,"total_display":"61,750.00","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096370,"accession":"0001128732-19-000010","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-23","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","shares_owned_after":163500.0,"shares_owned_after_display":"163,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096368,"accession":"0001128732-19-000010","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-22","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":20000.0,"total_display":"20,000.00","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096366,"accession":"0001128732-19-000010","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-21","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","shares_owned_after":220500.0,"shares_owned_after_display":"220,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096365,"accession":"0001128732-19-000010","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-20","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1500.0,"total_display":"1,500.00","shares_owned_after":217500.0,"shares_owned_after_display":"217,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096363,"accession":"0001128732-19-000010","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-19","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1250.0,"total_display":"1,250.00","shares_owned_after":223500.0,"shares_owned_after_display":"223,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096361,"accession":"0001128732-19-000010","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-18","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","shares_owned_after":215500.0,"shares_owned_after_display":"215,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096359,"accession":"0001128732-19-000010","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-17","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":0.5,"price_display":"0.50","price_state":"stated","total_value":1000.0,"total_display":"1,000.00","shares_owned_after":213500.0,"shares_owned_after_display":"213,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096357,"accession":"0001128732-19-000010","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-16","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","shares_owned_after":356000.0,"shares_owned_after_display":"356,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2019-04-17","scope":"insider"},{"id":8096355,"accession":"0001128732-19-000010","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-15","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":0.75,"price_display":"0.75","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","shares_owned_after":256000.0,"shares_owned_after_display":"256,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2019-04-17","scope":"insider"},{"id":8096353,"accession":"0001128732-19-000010","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-14","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":30000.0,"total_display":"30,000.00","shares_owned_after":226000.0,"shares_owned_after_display":"226,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-15","filed_date":"2019-04-17","scope":"insider"},{"id":7918042,"accession":"0001128732-19-000011","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001128732-19-000011","line_url":"/filing/0001128732-19-000011#line-5","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35000.0,"shares_display":"35,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":35000.0,"total_display":"35,000.00","shares_owned_after":202000.0,"shares_owned_after_display":"202,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-12-14","filed_date":"2019-04-18","scope":"insider"},{"id":8096351,"accession":"0001128732-19-000010","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-13","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","shares_owned_after":512000.0,"shares_owned_after_display":"512,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2019-04-17","scope":"insider"},{"id":8096349,"accession":"0001128732-19-000010","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-12","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","shares_owned_after":471000.0,"shares_owned_after_display":"471,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2019-04-17","scope":"insider"},{"id":8096347,"accession":"0001128732-19-000010","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-11","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":15000.0,"total_display":"15,000.00","shares_owned_after":456000.0,"shares_owned_after_display":"456,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2019-04-17","scope":"insider"},{"id":8096345,"accession":"0001128732-19-000010","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-10","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","shares_owned_after":499000.0,"shares_owned_after_display":"499,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2019-04-17","scope":"insider"},{"id":7918040,"accession":"0001128732-19-000011","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001128732-19-000011","line_url":"/filing/0001128732-19-000011#line-4","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","shares_owned_after":237000.0,"shares_owned_after_display":"237,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2019-04-18","scope":"insider"},{"id":7918036,"accession":"0001128732-19-000011","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001128732-19-000011","line_url":"/filing/0001128732-19-000011#line-3","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","shares_owned_after":247000.0,"shares_owned_after_display":"247,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-08-11","filed_date":"2019-04-18","scope":"insider"},{"id":8096340,"accession":"0001128732-19-000010","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-7","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":3000.0,"total_display":"3,000.00","shares_owned_after":537000.0,"shares_owned_after_display":"537,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-31","filed_date":"2019-04-17","scope":"insider"},{"id":8096337,"accession":"0001128732-19-000010","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-6","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","shares_owned_after":540000.0,"shares_owned_after_display":"540,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-27","filed_date":"2019-04-17","scope":"insider"},{"id":8096335,"accession":"0001128732-19-000010","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-5","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":550000.0,"shares_owned_after_display":"550,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-07-10","filed_date":"2019-04-17","scope":"insider"},{"id":7918033,"accession":"0001128732-19-000011","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001128732-19-000011","line_url":"/filing/0001128732-19-000011#line-2","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","shares_owned_after":250000.0,"shares_owned_after_display":"250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2019-04-18","scope":"insider"},{"id":7918028,"accession":"0001128732-19-000011","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001128732-19-000011","line_url":"/filing/0001128732-19-000011#line-1","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":0.0,"price_display":null,"price_state":"not-stated","total_value":0.0,"total_display":null,"shares_owned_after":275000.0,"shares_owned_after_display":"275,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2019-04-18","scope":"insider"},{"id":8096326,"accession":"0001128732-19-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001128732-19-000010","line_url":"/filing/0001128732-19-000010#line-1","is_derivative":false,"issuer_cik":"0001081938","issuer_name":"CANNAPHARMARX, INC.","issuer_ticker":"CPMD","issuer_name_source":null,"issuer_url":"/issuer/0001081938","owner_cik":"0001618233","owner_name":"Herick Gary J","owner_url":"/insider/0001618233","role":"Director, Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":860000.0,"shares_owned_after_display":"860,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-03-09","filed_date":"2019-04-17","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":27,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":27},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001081938","name":"CANNAPHARMARX, INC.","url":"/issuer/0001081938","role":"Director, Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2019-04-17","last_seen":"2019-04-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001618233","retrieved_at":"2026-08-21T04:40:50+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}